Earnings results might Drive Its Stock Price NASDAQ:MDB, NASDAQ:DTIL, NYSEAMERICAN:NSPR, NYSE:AVD

MONGODB (NASDAQ:MDB) EARNINGS INFORMATION (NASDAQ:MDB)

MongoDB last announced its earnings results on March 8th, 2021. The reported ($0.33) EPS for the quarter, topping the consensus estimate of ($0.39) by $0.06. The company earned $171 million during the quarter, compared to analysts’ expectations of $157.05 million. Its quarterly revenue was up 38.4% on a year-over-year basis. MongoDB has generated ($2.36) earnings per share over the last year. MongoDB has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, June 3rd, 2021 based off prior year’s report dates.

IS MONGODB A BUY RIGHT NOW? (NASDAQ:MDB)

13 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for MongoDB in the last twelve months. There are currently 3 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” MongoDB stock.
MongoDB

PRECISION BIOSCIENCES EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:DTIL)

IS PRECISION BIOSCIENCES A BUY RIGHT NOW? (NASDAQ:DTIL)

6 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Precision BioSciences in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Precision BioSciences stock.
Precision BioSciences

INSPIREMD (NYSEAMERICAN:NSPR) EARNINGS INFORMATION (NYSEAMERICAN:NSPR)

InspireMD last issued its quarterly earnings data on March 9th, 2021. The medical equipment provider reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by $0.02. InspireMD has generated ($4.80) earnings per share over the last year. InspireMD has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, May 11th, 2021 based off prior year’s report dates.

IS INSPIREMD A BUY RIGHT NOW? (NYSEAMERICAN:NSPR)

2 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for InspireMD in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” InspireMD stock.
InspireMD

AMERICAN VANGUARD EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NYSE:AVD)

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN AMERICAN VANGUARD? (NYSE:AVD)

Wall Street analysts have given American Vanguard a “N/A” rating, but there may be better short-term opportunities in the market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but American Vanguard wasn’t one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat’s top stock picks here.